SGLT2 inhibitors: approved for adults and cats but not for children with CKD

Nephrol Dial Transplant. 2024 May 31;39(6):907-909. doi: 10.1093/ndt/gfae029.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Adult
  • Animals
  • Cats
  • Child
  • Diabetes Mellitus, Type 2 / complications
  • Diabetes Mellitus, Type 2 / drug therapy
  • Drug Approval
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Renal Insufficiency, Chronic* / complications
  • Renal Insufficiency, Chronic* / drug therapy
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Hypoglycemic Agents